Health

Results: 1297-1308 of 10145

Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-1

PR Newswire associated0

Angel Yeast Showcases Yeast-Based Innovations for Animal Nutrition at TUYEM 2026

Cardiolife Partners with Bhutan Ministry of Health to Strengthen Nationwide Cardiac Care

Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT® in Aggressive Brain Cancer (Glioblastoma)

Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy

PR Newswire associated0

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data

Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference

LivaNova Appoints Anne Liddy as Chief Legal Officer

K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making.

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange